Clinical Trial Update: The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular Carcinoma [NA]

View source ↗

Summary

This entry announces the withdrawal of a clinical trial evaluating postoperative interferon-alpha treatment in p48-positive hepatocellular carcinoma patients. S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | NA | Status: WITHDRAWN